Food Design for Improved Day-long Glycaemic Regulation

August 26, 2016 updated by: Lund University

The Effect on Glucose Tolerance at a Second Meal Provided After Breakfast Meal Giving Late Increment in Postprandial Glycaemia

The study focus is on the possible improvement in glucose tolerance at a second standardized meal that can be achieved when preceded by a test meal with a low GI and a high GP.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

A study in healthy subjects using spaghetti as the test breakfast and a white wheat bread as the reference. Glycaemia, insulinaemia, NEFA, TG and subjective appetite are studied up to the time of the lunch meal that is served 4h after breakfast. After lunch the blood sampling continues for 2 hours.

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • BMI 19-25

Exclusion Criteria:

  • Smoker, Diabetes, Gluten intolerance, vegetarian

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Reference
White wheat bread
Other: Reference
the reference product used
Other Names:
  • WWB
Other: Test product
The test Product used
Other Names:
  • Pasta
Other: Test product
Pasta
Other: Reference
the reference product used
Other Names:
  • WWB
Other: Test product
The test Product used
Other Names:
  • Pasta

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Glucose
Time Frame: 0-6 h
0-6 h

Secondary Outcome Measures

Outcome Measure
Time Frame
Non-esterified fatty acids (NEFA)
Time Frame: 0-6 h
0-6 h
Triglycerides (TG)
Time Frame: 0-6 h
0-6 h
Appetite rating (Visual Analogue Scale)
Time Frame: 0-6 h
0-6 h
Insulin
Time Frame: 0-6 h
0-6 h

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Lund University

Investigators

  • Study Director: Elin Östman, Ass prof, Food for Health Science Centre (Medicon Village) - Lund University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2014

Primary Completion (Actual)

December 1, 2014

Study Completion (Actual)

March 1, 2015

Study Registration Dates

First Submitted

August 18, 2016

First Submitted That Met QC Criteria

August 22, 2016

First Posted (Estimate)

August 23, 2016

Study Record Updates

Last Update Posted (Estimate)

August 29, 2016

Last Update Submitted That Met QC Criteria

August 26, 2016

Last Verified

August 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • AFC-GPSecMeal

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Poor Glycemic Control

Clinical Trials on Reference

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Japan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe